Lilly schizophrenia drug gets positive opinion Hays Pharma, UK - 29 Sep 2008 "Because of the chronic and severe nature of schizophrenia, persistent challenges with adherence and the limited number of depot formulations available, ...
Posted in Schizophrenia in the News |
Comments are closed.